Categories Earnings, Technology

MicroVision stock stumbles after reporting Q1 earnings results

MicroVision’s (MVIS) bottom line and topline for Q1 2019 came in line with analysts’ expectations. The company reported a loss of 8 cents per share on revenuve of $1.85 million for the first quarter ended March 31, 2019. On average, analysts had expected MicroVision to post a loss of 8 cents per share on revenue of $1.85 million. MVIS stock, which closed up 15.53% at $1.19 yesterday, plunged about 9% in premarket trading hours.

MicroVision Q1 2019 earnings results

Net loss widened to $8.1 million in the recently ended quarter from $7.1 million in the prior-year quarter. Revenue decreased 15% year-over-year to $1.85 million.

“We remain on track with our business plan and are working to have products in the market in the second half of this year. We expect the development portion of our April 2017 agreement with a leading technology company to be completed in Q2 and we expect orders for production units shortly,” said CEO Perry Mulligan.

Total operating expenses increased to $8.67 million from $7.44 million in the first quarter of 2018. Cash and cash equivalents stood at $6.98 million as of March 31, 2019 compared to $13.77 million at the end of December 31, 2018.

The Redmond, Washington-based tech firm had stated in the recent annual filing that it had incurred substantial losses since inception and expects to incur a significant loss during the fiscal year ending December 31, 2019.

Shares of MicroVision have jumped 97% since the beginning of 2019 and dropped 8% in the past 12 months period.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Key metrics from Southwest Airlines’ (LUV) Q2 2024 earnings results

Southwest Airlines Co. (NYSE: LUV) reported its second quarter 2024 earnings results today. Total operating revenues increased 4.5% year-over-year to $7.4 billion. Net income decreased 46.3% to $367 million, or

AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase in revenues. The numbers exceeded estimates. The company

Hasbro (HAS) Q2 2024 Earnings: Key financials and quarterly highlights

Hasbro, Inc. (NASDAQ: HAS) reported its second quarter 2024 earnings results today. Net revenues decreased 18% year-over-year to $995.3 million. Net earnings attributable to Hasbro Inc. were $138.5 million, or

Add Comment
Viewing Highlight